- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Omada Health, Inc. Common Stock(OMDA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for OMDA
11/13/2026: OMDA (1-star) is currently NOT-A-BUY. Pass it for now.
Omada Health is a publicly traded digital health company that provides virtual-first chronic care management for cardiometabolic and musculoskeletal conditions. The company's strengths include a strong, evidence-based clinical platform and strategic hardware partnerships, which have fueled significant customer adoption among large enterprises. Its primary growth opportunity lies in its ability to support members managing GLP-1 weight-loss medications through remote coaching. However, investors must weigh these strengths against risks such as intense competition from major telehealth players, dependency on contract renewals, and execution risks following recent executive leadership changes. The stock may suit growth-oriented investors who are comfortable with the inherent volatility of the early-stage digital health market.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in a high-growth sector with proven revenue momentum and a scalable digital platform. |
| Momentum investor | Mixed fit | Momentum investors should monitor for sustained positive price action and volume signals. |
| Value investor | Weak fit | The company is a growth-stage entity and current valuations reflect future potential rather than traditional value metrics. |
| Dividend investor | Weak fit | Omada does not pay a dividend and is focused on reinvesting cash flow into market expansion. |
| Low-risk investor | Weak fit | High volatility and the risks associated with the early-stage public market performance make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock has displayed significant intraday and long-term price fluctuations typical of growth-stage healthcare IPOs. |
| Valuation risk | Medium / high | As a growth company, the stock's valuation is highly dependent on achieving future revenue growth targets. |
| Competition risk (Digital Health incumbents) | High | Intense pressure from larger, established telehealth players threatens to compress margins and market share. |
| Business quality | Medium | While the clinical platform is robust, the company is still building a consistent track record of profitability. |
| Dividend income | Low / none | The company does not provide income through dividends. |
| Execution risk | Medium / high | Successfully managing the transition to a new CEO and scaling operations to meet client demand is critical for future performance. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 889.00M USD | Price to earnings Ratio 35.83 | 1Y Target Price 26.92 |
Price to earnings Ratio 35.83 | 1Y Target Price 26.92 | ||
Volume (30-day avg) 1.2M shares | Beta - | 52 Weeks Range 10.28 - 25.45 | Updated Date 11/14/2026 |
52 Weeks Range 10.28 - 25.45 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Health Information Services
- BUY participation
- 100.0%
- Active BUY / eligible
- 4 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit 23.25% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Chronic Care Services | Subscription-based contracts with health plans, employers, and health systems for digital chronic disease management. | Revenue is primarily driven by recurring service fees paid by large organizations to help their members stay healthy. |
| Connected Device Integration | Incorporation of monitoring device costs (e.g., blood pressure cuffs, scales, CGMs) into service contracts. | The company earns revenue by acting as a provider of both the digital software and the physical monitoring tools. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 0.02 | Actual 0.1 |
Profitability
Profit Margin 4.21% | Operating Margin (TTM) 2.06% |
Management Effectiveness
Return on Assets (TTM) 1.35% | Return on Equity (TTM) 5.72% |
Valuation
Trailing PE 35.83 | Forward PE 44.64 | Enterprise Value 718.77M | Price to Sales(TTM) 2.67 |
Enterprise Value 718.77M | Price to Sales(TTM) 2.67 | ||
Enterprise Value to Revenue 2.16 | Enterprise Value to EBITDA 34.96 | Shares Outstanding 62.04M | Shares Floating 51.85M |
Shares Outstanding 62.04M | Shares Floating 51.85M | ||
Percent Insiders 2.12 | Percent Institutions 87.21 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

